Evidence map›Paper›PMID 31126983›Full record

ReviewMolecular & cellular proteomics : MCP2019

Exploiting Interdata Relationships in Next-generation Proteomics Analysis.

Burcu Vitrinel, Hiromi W L Koh, Funda Mujgan Kar, Shuvadeep Maity, Justin Rendleman, Hyungwon Choi, Christine Vogel

Open access · hybridAbstract readReview
In one paragraph

Review in Molecular & cellular proteomics : MCP, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 47 citations in OpenAlex.

  1. Integration ofFrontiers in immunology · 2023
    Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Proteomic/transcriptomic analysis of erythropoiesis.Current opinion in hematology · 2021
    Review
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Burcu VitrinelCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY.
Hiromi W L KohDepartment of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore; Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research, Singapore.
Funda Mujgan KarCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY.
Shuvadeep MaityCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY.
Justin RendlemanCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY.
Hyungwon ChoiDepartment of Medicine, Yong Loo Lin School of Medicine, National University Singapore, Singapore; Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research, Singapore.
Christine VogelCenter for Genomics and Systems Biology, Department of Biology, New York University, New York, NY. Electronic address: cvogel@nyu.edu.
New York University · USAgency for Science, Technology and Research · SGInstitute of Molecular and Cell Biology · SG

Funding

Next generation gene expression analysisR35GM127089 · NIGMS · NEW YORK UNIVERSITY · PI Christine Vogel · 2018 to 2026
$4.0M
American Heart Association-American Stroke Association 18PRE33990254NIGMS NIH HHS R35 GM127089
6 · The paper itself

Abstract

Mass spectrometry based proteomics and other technologies have matured to enable routine quantitative, system-wide analysis of concentrations, modifications, and interactions of proteins, mRNAs, and other molecules. These studies have allowed us to move toward a new field concerned with mining information from the combination of these orthogonal data sets, perhaps called "integromics." We highlight examples of recent studies and tools that aim at relating proteomic information to mRNAs, genetic associations, and changes in small molecules and lipids. We argue that productive data integration differs from parallel acquisition and interpretation and should move toward quantitative modeling of the relationships between the data. These relationships might be expressed by temporal information retrieved from time series experiments, rate equations to model synthesis and degradation, or networks of causal, evolutionary, physical, and other interactions. We outline steps and considerations toward such integromic studies to exploit the synergy between data sets.

Indexed as

ProteomicsAnimalsData AnalysisHumansSystems BiologyBioinformaticsComputational BiologyDegradomics*integrationMetabolomicsModelingmultiomicsPost-translational modifications*RNA SEQsystems biologySystems biology*Transcription*Translation*

Identifiers

PMID31126983
PMCPMC6692783
OpenAlexW2946008612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.